Pharmacologist
Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Maryland, United States
Yuqing Gong Ph.D. is currently a Senior Pharmacologist at the Quantitative Clinical Pharmacology Team in the Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research/FDA. Her current role in the division is to utilize quantitative tools such as population pharmacokinetics, modeling and simulations, to address specific questions relate to generic drug development process and/or regulatory decision making. Before joining the FDA, she received comprehensive trainings in pharmaceutical sciences with focuses on drug delivery, pharmacokinetics, and drug-drug interactions. Dr. Gong received her Ph.D. degree in Pharmaceutical Sciences at the University of Tennessee Health Science Center (Memphis, TN, US) in 2020. Her Ph.D. thesis work was to develop a nanoformulation for antiretroviral drugs to suppress the viral load in in the central nervous system across the blood-brain barrier. She also worked on projects that focused on pharmacokinetics and pharmacodynamics of antiretroviral drugs, especially on drug-drug interactions relate to cytochrome P450s.
Disclosure(s): No financial relationships to disclose
Tuesday, November 12, 2024
2:00 PM – 3:30 PM MST
